Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation

Isabelle Sermet-Gaudelus

首页> 外文期刊>European respiratory review >Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation

【24h】

Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation

机译：囊性纤维化和G551D-CFTR突变患者的依伐卡托治疗

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European respiratory review》 |2013年第127期|共页
作者
Isabelle Sermet-Gaudelus;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类呼吸系及胸部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial [J] . Alexandra Quittner, Ellison Suthoff, Regina Rendas-Baum, Health and Quality of Life Outcomes . 2015,第1期

机译：依伐卡托治疗对囊性纤维化和G551D-CFTR突变患者的影响：STRIVE随机对照试验中患者报告的结果
2. Case History: Kalydeco (R) (VX-770, Ivacaftor), a CFTR Potentiator for the Treatment of Patients with Cystic Fibrosis and the G551D-CFTR Mutation [J] . Hadida Sabine, Van Goor Frederick, Dinehart Kirk, Annual reports in medicinal chemistry. . 2014,第Null期

机译：病历：Kalydeco（R）（VX-770，Ivacaftor），一种CFTR增强剂，用于治疗囊性纤维化和G551D-CFTR突变的患者
3. Case History: Kalydeco (R) (VX-770, Ivacaftor), a CFTR Potentiator for the Treatment of Patients with Cystic Fibrosis and the G551D-CFTR Mutation [J] . Hadida Sabine, Van Goor Frederick, Dinehart Kirk, Annual reports in medicinal chemistry. . 2014,第Null期

机译：案例历史：KALYDECO（R）（VX-770，IVACAFTOR），一种用于治疗囊性纤维化患者和G551D-CFTR突变的CFTR强直剂
4. Cystic fibrosis transmembrane conductance regulator gene mutations cause 'black' pigment gallstone formation: new insights from mouse models and implications for therapeutic interventions in cystic fibrosis [C] . A. L. BRODERICK, H. WITTENBURG, M. A. LYONS, Falk Symposium . 2004

机译：囊性纤维化跨膜电导调节剂基因突变引起'黑色'颜料胆结石形成：来自小鼠模型的新见解，以及对囊性纤维化治疗干预的影响
5. Liposomal antimicrobial agent formulations for the treatment of pulmonary infection in cystic fibrosis patients. [D] . Halwani, Majed Abdulaziz. 2010

机译：脂质体抗微生物剂制剂，用于治疗囊性纤维化患者的肺部感染。
6. Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized controlled trial [O] . Alexandra Quittner, Ellison Suthoff, Regina Rendas-Baum, 2015

机译：依伐卡托治疗对囊性纤维化和G551D-CFTR突变患者的影响：STRIVE随机对照试验中患者报告的结果
7. Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial [O] . 2015

机译：依伐卡托治疗对囊性纤维化和G551D-CFTR突变患者的影响：STRIVE随机对照试验中患者报告的结果

Ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation

著录项

相似文献

相关主题

期刊订阅